# MYRBETRIQ
> **NDA202611** · New Drug Application · Sponsor: APGDI · Approved 2012-06-28
## Drug
- **FDA Application Number:** NDA202611
- **Application type:** New Drug Application
- **Brand name:** MYRBETRIQ
- **Generic name:** MIRABEGRON
- **Active ingredients:** MIRABEGRON
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** APGDI
- **Manufacturer:** Astellas Pharma US, Inc.
- **First approval:** 2012-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202611)
---
*MORVS · CC0 1.0*